| 000 | 01772 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515023629.0 | ||
| 264 | 0 | _c20060613 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1525-7304 | ||
| 024 | 7 |
_a10.3816/CLC.2006.n.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, Sheeba K | |
| 245 | 0 | 0 |
_aAsian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program. _h[electronic resource] |
| 260 |
_bClinical lung cancer _cMar 2006 |
||
| 300 |
_a326-31 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAsian People _xethnology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aFossella, Frank V | |
| 700 | 1 | _aLiu, Diane | |
| 700 | 1 | _aSchaerer, Rainell | |
| 700 | 1 | _aTsao, Anne S | |
| 700 | 1 | _aKies, Merrill S | |
| 700 | 1 | _aPisters, Katherine M | |
| 700 | 1 | _aBlumenschein, George R | |
| 700 | 1 | _aGlisson, Bonnie S | |
| 700 | 1 | _aLee, J Jack | |
| 700 | 1 | _aHerbst, Roy S | |
| 700 | 1 | _aZinner, Ralph G | |
| 773 | 0 |
_tClinical lung cancer _gvol. 7 _gno. 5 _gp. 326-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/CLC.2006.n.014 _zAvailable from publisher's website |
| 999 |
_c16243773 _d16243773 |
||